greetings and opening remarks

16
Community College Program Welcome

Upload: bio-link

Post on 23-Jan-2015

1.170 views

Category:

Documents


6 download

DESCRIPTION

Welcoming message given by Sonia Wallman, of the Organizing Committee, and Lance Hartford, the Executive Director of the Massachusetts Biotechnology Education Foundation.

TRANSCRIPT

Page 1: Greetings and Opening Remarks

Community College Program

Welcome

Page 2: Greetings and Opening Remarks

Annual Community College Program Day

Organizing Committee

• Sonia Wallman – Executive Director NBC2• Elaine Johnson – Bio-Link Director• Russ Read – National Center, NC BioNetwork• Lance Hartford – MassBioEd Foundation• Margaret Bryans – PI NBC2, Montgomery County

Community College• Lisa Seidman – Madison Area Technical College • Tim Dubuque - NBC2

Page 3: Greetings and Opening Remarks
Page 4: Greetings and Opening Remarks

Massachusetts BioPharma Employment Continues Growth

The industry weathered the 2009 downturn without an employment drop.

53%Growthsince 2002 Source: U.S. Census, County Business Patterns and MassBio formula and analysis.

*2011 figure is a preliminary estimate based on review of Massachusetts ES-202 data for 2010-2011.

Page 5: Greetings and Opening Remarks

Biotechnology R&D Employment

According to the Bureau of Labor Statistics’ Quarterly Census of Employment & Wage (QCEW) data, Massachusetts leads the nation in biotechnology research & development employment.

Source: U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages (QCEW)

2007 2010CA 19,134 21,616CT 2,452 1,582MA 24,565 26,807MD 10,154 9,469MI 4,670 2,759MO 4,262 3,874NJ 8,567 9,224NY 2,679 3,553NC 7,042 6,275PA 15,902 12,776WA 2,499 3,730

Page 6: Greetings and Opening Remarks

Total Trials PC  I  II III PA% of US 9.41% 11.00% 11.99% 8.26% 8.46% 3.89%% of Global 4.91% 5.88% 6.43% 4.56% 3.52% 1.44%

Drug Development Pipeline, August 2011

Pre-Clinical 316

Phase I 216

Phase II 275

Phase III 76

Pending Approval 14

Candidate medicines of Massachusetts-headquartered* companies, by clinical trials stage

Massachusetts-headquartered companies’ share of U.S. and Global drug development pipeline

* There are many drugs in development in Massachusetts by companies with headquarters located outside of Massachusetts. These candidate drugs are not included in any Massachusetts pipeline estimates found in this report.

Massachusetts- headquartered companies* account for about 10% of the U.S. drug development pipeline and 5% of the global pipeline.

Source: MedTrack Online, Life Sciences Analytics, Inc.

Page 7: Greetings and Opening Remarks

Of the 897 drugs in the Massachusetts pipeline, 42.7% are cancer drugs.

Drugs intended for the Central Nervous System (CNS) therapeutic area are next at 10.1% of the pipeline.

Massachusetts Pipeline by Therapeutic Area

Total Trials CompaniesCancer 383 59Central Nervous System 91 35Infectious 84 30Autoimmune and Inflammation 61 33Metabolic/Endocrinology 47 23Ophthalmology and Optometry 32 13Respiratory and Pulmonary System 32 20Blood and Lymphatic System 30 16Cardiovascular & Circulatory 25 36Musculo-Skeletal-Disorders 24 11Digestive 19 15Dermotology 18 15Kidney & Genito-Urinary 13 10Genetic Diseases & Dysmorphic Syndromes 11 6Substance Abuse 10 5Women's Health 9 6Miscellaneous 8 7

Source: MedTrack Online, Life Sciences Analytics, Inc.

Page 8: Greetings and Opening Remarks

Source Data: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTreeTM Report, Historical Trend Data, and MassBio analysis.

Venture Capital Investment

$1.071 billion invested in MA biotechs in 2011 is an historic high.

$8.054billion since 2002

Page 9: Greetings and Opening Remarks

Source: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTreeTM Report, Historical Trend Data, MassBio

analysis.

MA Share of the Biotech VC Dollar

MA biotechs received 22.6% of all VC biotech financing, just below the 2010 all-time high.

Page 10: Greetings and Opening Remarks

Leading BioPharma Employers (MA), 2011

1. Genzyme (Sanofi) 4,3562. Pfizer 2,6003. Biogen Idec 2,3004. Novartis 2,1005. Thermo Fisher Scientific 1,7006. Shire 1,5007. Vertex 1,3108. EMD Millipore 1,2379. Parexel International 1,20010. Millenium: Takeda Oncology 1,05011. Charles River Laboratories 97012. AstraZeneca 90013. EMD Serono 85014. Hologic 80015. Abbott Laboratories 75016. Sunovion Pharmaceuticals (DSP) 69017. Nova Biomedical 63118. Cubist 62619. Lantheus 55019. Merck 33020. Bristol-Myers Squibb 320

Sources: MassBio, membership reports, survey, Boston Business Journal Book of Lists, 2011.

MA has benefited from the pharma industry’s embrace of biotechnology.

Page 11: Greetings and Opening Remarks

Mass Biomanufacturing

Of the top 11 biopharma manufacturing states, Massachusetts was one of just four which added manufacturing jobs in the last decade

Page 12: Greetings and Opening Remarks

$4,615,364,513 in payroll (2010)

$95,628 in average salary (2010)

BioPharma Industry Impact in MA

The estimated average salary in the biopharma industry is 77% higher than the estimated state average salary of $53,834.

Massachusetts Exports, 2010All Commodities 26,256,370,201Optic, Photo Etc, Medic Or Surgical Instrments Etc 5,324,511,940 20.20%Industrial Machinery, Including Computers 4,601,715,086Electric Machinery Etc; Sound Equip; Tv Equip; Pts 4,518,662,880Pharmaceutical Products 2,136,306,456 8.10%

Source: MassExport Center

Source: U.S. Census, County Business Patterns, MassBio estimate using 2009 base data .

Page 13: Greetings and Opening Remarks

430+Biotech

Companies

122Colleges &Universities

Top 5NIH fundedResearchHospitals

1stin

Venture Capital & SBIR funds per worker

1stin

Education Level of

workforce

500+BiopharmaCompanies

122Colleges &Universities

Top 5NIH funded

Research

Hospitals

1stin

Venture Capital & federal research

funds per worker

1stin

Education Level of

Workforce (US)

Why Massachusetts?

SupportiveLocal, State Government

Life Sciences InitiativeBiotech Caucus

Page 14: Greetings and Opening Remarks

The $1 Billion Massachusetts Life Sciences Initiative

• 10 years• $1 billionInvestment$5

00 m

illio

n C

apita

l

Fund

$250 million

Tax Incentive Program

$250m Investment Fund (subject to appropriation)

Over time, the industry demonstrated its value, commitment to the region, and promise for the future . . . and state government responded.

Page 15: Greetings and Opening Remarks

U.S. Department of Labor to receive the Trade Adjustment Assistance Community College and Career Training Grant. $20M

The Metro Boston Skilled Careers in Life Sciences (SCILS) initiative $5M – Life Sciences Center & Quincy College

Mass Life Science Center Internship Program - since the program first launched in 2009, the Center has placed 794 interns at more than 250 companies throughout Massachusetts!

MassBioEd Foundation’s industry endorsement of eight community college programs

Education and Workforce Development Initiatives

Page 16: Greetings and Opening Remarks

Northeast Biomanufacturers and Community Colleges with Biomanufacturing